| Mary V Henton, LMFT | |
|
7840 Washington Ave, Kansas City, KS 66112-2152 | |
| (913) 233-3303 | |
| (913) 233-3350 |
| Full Name | Mary V Henton |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 7840 Washington Ave, Kansas City, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285857151 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 832 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mary V Henton, LMFT 1429 E Stagecoach Dr, Olathe, KS 66062-2215 Ph: (913) 579-4909 | Mary V Henton, LMFT 7840 Washington Ave, Kansas City, KS 66112-2152 Ph: (913) 233-3303 |
News Archive
VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted against the following question: "Based on the current available data, do you believe the overall benefit-risk assessment of PHEN/TPM (QNEXA) is favorable to support its approval for the treatment of obesity in individuals with a BMI > 30 kg/m2 or > 27 kg/m2 with weight-related co-morbidities?" The three co-morbidities included hypertension, diabetes and dyslipidemia.
Researchers from University Hospitals (UH) Case Medical Center's Seidman Cancer Center will present findings from a study that found the presence of tumor-infiltrating lymphocytes, a type of white blood cell, ahead of treatment may help predict response to platinum-based chemotherapy in women with triple-negative breast cancer.
Most people know that high cholesterol levels place them at increased risk for heart disease and stroke. Prior research has shown that particular types of strokes contribute to one's risk for depression, and that abnormal blood lipid levels can increase the risk of depression in the elderly.
International Stem Cell Corporation and Sankara Nethralaya, announced today commencement of a collaboration to develop ISCO's "CytoCor™" stem cell-derived corneal tissue. The goal is to use CytoCor to treat corneal blindness and vision impairment. "This is one more step in ISCO's stated plan of building its portfolio of therapeutic agents through strategic alliances throughout the world," said Chairman, Ken Aldrich.
It won't tackle global carbon emissions yet, but a new technology from Australia's national science agency, CSIRO, has found a way to pull carbon dioxide (CO2) out of the atmosphere and put it into beer and other beverages.
› Verified 9 days ago
Mrs. Andrea Campbell, LMFT-T Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 7840 Washington Ave, Kansas City, KS 66112 Phone: 913-563-6500 Fax: 913-328-4604 | |
Diane Victory, LCMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 7840 Washington Ave, Kansas City, KS 66112 Phone: 913-563-6500 | |
Dr. Linda Buxbaum Bass, PHD, LCMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 155 S 18th St, Suite 222, Kansas City, KS 66102 Phone: 913-963-0784 | |
Mr. Jared Lloyd Cristy, TLMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 757 Armstrong Ave, Kansas City, KS 66101 Phone: 913-233-3336 | |
Bronwyn Burkhardt, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1301 N 47th St, Kansas City, KS 66102 Phone: 816-969-0531 | |
Justin J Bastin, LMFT Couples Therapy Medicare: Medicare Enrolled Practice Location: 2300 Hutton Rd Ste 112, Kansas City, KS 66109 Phone: 816-343-8452 Fax: 913-745-6155 |